NORTHWEST BIOTHERAPEUTICS INC: cashflow_financing
| Value | {"amount": 40843000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2024-01-01 – 2024-09-30 |
| Status | current |
| Entity | NORTHWEST BIOTHERAPEUTICS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:38:52.834193+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/db64d35a-7729-47c2-a7d0-e98466b2f5c7
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001410578-24-001879 · Open the official SEC filing →Retrieved: 2026-08-19T10:38:52.834193+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001072379/cashflow-financing/2024-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/db64d35a-7729-47c2-a7d0-e98466b2f5c7
History
- no predecessors — first report